Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD

BACKGROUND: Data comparing systemic exposure and systemic vascular endothelial growth factor (VEGF) suppression of ranibizumab, bevacizumab and aflibercept following intravitreal injection are lacking. METHODS: Fifty-six patients with wet age-related macular degeneration received intravitreal ranibi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Br J Ophthalmol
Autores principales: Avery, Robert L, Castellarin, Alessandro A, Steinle, Nathan C, Dhoot, Dilsher S, Pieramici, Dante Joseph, See, Robert, Couvillion, Stephen, Nasir, Ma'an A, Rabena, Melvin D, Le, Kha, Maia, Mauricio, Visich, Jennifer E
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2014
Materias:
Clinical Science
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4251300/
https://ncbi.nlm.nih.gov/pubmed/25001321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2014-305252
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares